JPH05508651A - スルホニルプリスチナマイシンiibの製造方法 - Google Patents
スルホニルプリスチナマイシンiibの製造方法Info
- Publication number
- JPH05508651A JPH05508651A JP91512349A JP51234991A JPH05508651A JP H05508651 A JPH05508651 A JP H05508651A JP 91512349 A JP91512349 A JP 91512349A JP 51234991 A JP51234991 A JP 51234991A JP H05508651 A JPH05508651 A JP H05508651A
- Authority
- JP
- Japan
- Prior art keywords
- pristinamycin
- water
- sulfonyl
- yield
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 title claims description 25
- 108010015791 Streptogramin A Proteins 0.000 title claims description 4
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 title description 13
- DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 claims description 23
- RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 claims description 22
- 108010079780 Pristinamycin Proteins 0.000 claims description 22
- 229960003961 pristinamycin Drugs 0.000 claims description 22
- YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 19
- -1 alkali metal tungstate Chemical class 0.000 claims description 15
- 238000007254 oxidation reaction Methods 0.000 claims description 15
- 230000003647 oxidation Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 8
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical group [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 claims description 8
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 claims 1
- DAIKHDNSXMZDCU-FQTGFAPKSA-N pristinamycin IIA Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2 DAIKHDNSXMZDCU-FQTGFAPKSA-N 0.000 claims 1
- DAIKHDNSXMZDCU-UHFFFAOYSA-N pristinamycin component IIA Natural products C1C(=O)CC(O)C=C(C)C=CCNC(=O)C=CC(C)C(C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2 DAIKHDNSXMZDCU-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 150000003457 sulfones Chemical class 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- QWMFKVNJIYNWII-UHFFFAOYSA-N 5-bromo-2-(2,5-dimethylpyrrol-1-yl)pyridine Chemical compound CC1=CC=C(C)N1C1=CC=C(Br)C=N1 QWMFKVNJIYNWII-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- JPJALAQPGMAKDF-UHFFFAOYSA-N selenium dioxide Chemical compound O=[Se]=O JPJALAQPGMAKDF-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- NSFIAKFOCAEBER-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(4-methylphenyl)butanedioic acid Chemical compound C1=CC(C)=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=C(C)C=C1 NSFIAKFOCAEBER-UHFFFAOYSA-N 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- YGXCETJZBDTKRY-UHFFFAOYSA-N Pristinamycin Component I A Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O YGXCETJZBDTKRY-UHFFFAOYSA-N 0.000 description 1
- 108010015795 Streptogramin B Proteins 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- AAQNGTNRWPXMPB-UHFFFAOYSA-N dipotassium;dioxido(dioxo)tungsten Chemical compound [K+].[K+].[O-][W]([O-])(=O)=O AAQNGTNRWPXMPB-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000004966 inorganic peroxy acids Chemical class 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- YGXCETJZBDTKRY-DZCVGBHJSA-N pristinamycin IA Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YGXCETJZBDTKRY-DZCVGBHJSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heat Treatment Of Sheet Steel (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (4)
- 1.アルカリ金属タングステン酸塩の存在下での二相媒体中での10〜25℃の 間の温度における3.5〜20当量の過酸化水素を用いる一般式: ▲数式、化学式、表等があります▼(II)[式中、 AlKは線状または分枝鎖状のアルキレン基を表し、そしてRは線状または分枝 鎖状のアルキル基を表し、これらの基の炭素数は1−10である]の26−[( 2−ジアルキルアミノアルキル)チオ]プリスチナマイシンHaの酸化による、 一般式: ▲数式、化学式、表等があります▼(I)[式中、 AlKおよびRは以上で定義されている如くである]の26−[(2−ジアルキ ルアミノアルキル)スルホニル]プリスチナマイシンIIaの製造方法。
- 2.アルカリ金属タングステン酸塩がタングステン酸ナトリウムであることを特 徴とする、請求の範囲1に記載の方法。
- 3.アルカリ金属タングステン酸塩を5−0.5モル%の割合で加えることを特 徴とする、請求の範囲1に記載の方法。
- 4.二相媒体が水/塩素化された溶媒または水/n−ブタノール混合物からなる ことを特徴とする、請求の範囲1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR90/09033 | 1990-07-16 | ||
FR909009033A FR2664597B1 (fr) | 1990-07-16 | 1990-07-16 | Procede de preparation de sulfonylpristinamycine iib. |
PCT/FR1991/000579 WO1992001692A1 (fr) | 1990-07-16 | 1991-07-15 | Procede de preparation de sulfonylpristinamycine ii¿b? |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05508651A true JPH05508651A (ja) | 1993-12-02 |
JP3345811B2 JP3345811B2 (ja) | 2002-11-18 |
Family
ID=9398751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51234991A Expired - Lifetime JP3345811B2 (ja) | 1990-07-16 | 1991-07-15 | スルホニルプリスチナマイシンiibの製造方法 |
Country Status (21)
Country | Link |
---|---|
US (1) | US5347001A (ja) |
EP (1) | EP0539484B1 (ja) |
JP (1) | JP3345811B2 (ja) |
KR (1) | KR100199068B1 (ja) |
AT (1) | ATE147744T1 (ja) |
AU (1) | AU654145B2 (ja) |
CA (1) | CA2082636C (ja) |
DE (1) | DE69124241T2 (ja) |
DK (1) | DK0539484T3 (ja) |
ES (1) | ES2095946T3 (ja) |
FI (1) | FI100884B (ja) |
FR (1) | FR2664597B1 (ja) |
GR (1) | GR3022284T3 (ja) |
IE (1) | IE912446A1 (ja) |
IL (1) | IL98851A (ja) |
NZ (1) | NZ238948A (ja) |
PT (1) | PT98334B (ja) |
RU (1) | RU2073002C1 (ja) |
TW (1) | TW197438B (ja) |
WO (1) | WO1992001692A1 (ja) |
ZA (1) | ZA915443B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2664598A1 (fr) * | 1990-07-16 | 1992-01-17 | Rhone Poulenc Rorer Sa | Procede de preparation de sulfinyl pristinamycine iib. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
GB8616768D0 (en) * | 1986-07-09 | 1986-08-13 | May & Baker Ltd | Process |
GB2206577B (en) * | 1987-07-07 | 1990-10-24 | May & Baker Ltd | New process for the preparation of therapeutically useful pristinamycin iib sulphone derivatives |
AU621076B2 (en) * | 1987-12-25 | 1992-03-05 | Sumitomo Pharmaceuticals Company, Limited | Process for preparation of sulfone derivatives |
-
1990
- 1990-07-16 FR FR909009033A patent/FR2664597B1/fr not_active Expired - Lifetime
-
1991
- 1991-07-12 IE IE244691A patent/IE912446A1/en not_active IP Right Cessation
- 1991-07-12 ZA ZA915443A patent/ZA915443B/xx unknown
- 1991-07-12 NZ NZ238948A patent/NZ238948A/en not_active IP Right Cessation
- 1991-07-15 AU AU82221/91A patent/AU654145B2/en not_active Expired
- 1991-07-15 KR KR1019930700113A patent/KR100199068B1/ko not_active IP Right Cessation
- 1991-07-15 CA CA002082636A patent/CA2082636C/fr not_active Expired - Lifetime
- 1991-07-15 RU RU9192016441A patent/RU2073002C1/ru active
- 1991-07-15 IL IL9885191A patent/IL98851A/xx not_active IP Right Cessation
- 1991-07-15 US US07/961,915 patent/US5347001A/en not_active Expired - Lifetime
- 1991-07-15 DE DE69124241T patent/DE69124241T2/de not_active Expired - Lifetime
- 1991-07-15 DK DK91913608.5T patent/DK0539484T3/da active
- 1991-07-15 AT AT91913608T patent/ATE147744T1/de not_active IP Right Cessation
- 1991-07-15 ES ES91913608T patent/ES2095946T3/es not_active Expired - Lifetime
- 1991-07-15 EP EP91913608A patent/EP0539484B1/fr not_active Expired - Lifetime
- 1991-07-15 JP JP51234991A patent/JP3345811B2/ja not_active Expired - Lifetime
- 1991-07-15 WO PCT/FR1991/000579 patent/WO1992001692A1/fr active IP Right Grant
- 1991-07-16 TW TW080105509A patent/TW197438B/zh not_active IP Right Cessation
- 1991-07-16 PT PT98334A patent/PT98334B/pt not_active IP Right Cessation
-
1992
- 1992-12-11 FI FI925643A patent/FI100884B/fi not_active IP Right Cessation
-
1997
- 1997-01-16 GR GR960402521T patent/GR3022284T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ238948A (en) | 1992-10-28 |
DE69124241T2 (de) | 1997-05-15 |
TW197438B (ja) | 1993-01-01 |
FI925643A0 (fi) | 1992-12-11 |
AU654145B2 (en) | 1994-10-27 |
FI100884B (fi) | 1998-03-13 |
FR2664597B1 (fr) | 1994-09-02 |
KR100199068B1 (ko) | 1999-06-15 |
WO1992001692A1 (fr) | 1992-02-06 |
IE912446A1 (en) | 1992-01-29 |
GR3022284T3 (en) | 1997-04-30 |
CA2082636A1 (fr) | 1992-01-17 |
FR2664597A1 (fr) | 1992-01-17 |
DE69124241D1 (de) | 1997-02-27 |
IL98851A0 (en) | 1992-07-15 |
ES2095946T3 (es) | 1997-03-01 |
ZA915443B (en) | 1993-03-31 |
JP3345811B2 (ja) | 2002-11-18 |
CA2082636C (fr) | 2002-05-21 |
IL98851A (en) | 1995-08-31 |
EP0539484B1 (fr) | 1997-01-15 |
PT98334B (pt) | 1999-01-29 |
ATE147744T1 (de) | 1997-02-15 |
AU8222191A (en) | 1992-02-18 |
RU2073002C1 (ru) | 1997-02-10 |
KR930701449A (ko) | 1993-06-11 |
PT98334A (pt) | 1992-06-30 |
FI925643A (fi) | 1992-12-11 |
US5347001A (en) | 1994-09-13 |
DK0539484T3 (da) | 1997-03-03 |
EP0539484A1 (fr) | 1993-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61200101A (ja) | 部分メチル化シクロデキストリン及びその製造方法 | |
US3005852A (en) | Production of sulfoxides and sulfones | |
US3006963A (en) | Production of sulfoxides and sulfones | |
JPH05502232A (ja) | スクラレオリドの製造方法 | |
JPH05508651A (ja) | スルホニルプリスチナマイシンiibの製造方法 | |
Smith | Ketoxime-O-sulfonic Acids1 | |
Kulka | Electrolytic Oxidation of Quinoline and 3-Picoline | |
US3009952A (en) | Preparation of halogenated isophthalic acids | |
Tanaka et al. | Synthesis of 3-Chloro-. DELTA. 3-cephem-4-carboxylate by Addition/Cyclization of Allenecarboxylate. Copper (II)-Promoted Aerobic Oxidation of Arenesulfinic Acids. | |
JP4310820B2 (ja) | カルバゾクロムスルホン酸誘導体の製法 | |
WO1994021603A1 (en) | A process for preparing sulfones | |
SU453404A1 (ru) | Способ получения пиразол-3-карбоновых кислот | |
CA1145757A (en) | Novel process to produce 5-mercaptotetrazoyl -1 acetic acid | |
US4546203A (en) | Facile synthesis of β-hydroxy-β-methylglutaric acid | |
Ellis Jr et al. | Novel biphasic synthesis of porphyrin | |
JPS63310874A (ja) | 5−フエニルスルフイニル−1h−2−(メトキシカルボニルアミノ)−ベンズイミダゾ−ルの製法 | |
EP0539451B1 (fr) | Vinylsulfonyl pristinamycine et sa preparation | |
JPS6111953B2 (ja) | ||
Takahashi et al. | Syntheses of Heterocyclic Compounds of Nitrogen. LXXXVIII.: Phenyl Pyridyl Ethers.(8). | |
JPH02771A (ja) | チアンフェニコールの製造法 | |
DK146823B (da) | Fremgangsmaade til fremstilling af vindesinmonosulfat | |
CN113387848A (zh) | 一种制备磺酰胺类化合物的合成工艺 | |
JPH047738B2 (ja) | ||
IL127969A (en) | Process for the preparation of clarithromycin from its 9-hydrazone | |
JPS5923296B2 (ja) | 2↓−ヒドロキシ↓−3↓−ハロゲノ↓−1・4↓−ナフトキノンの銅塩の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080906 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080906 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090906 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100906 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100906 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110906 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term |